mpox Archive — Page 1 of 1

Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.
September 22, 2022

Vanderbilt study uses AI to speed mpox drug trials

A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

By Paul Govern
Gloved hands hold a blood sample tube labeled “Monkeypox,” with the positive box checked.
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.

By Bill Snyder
Alison Benton, SMB, and David Gaston, MD, PhD, discuss pcr data analysis as they prepare to begin in-house monkey pox testing for VUMC-affiliated practices.
August 31, 2022

Monkeypox testing available for eligible VUMC patients

Vanderbilt University Medical Center is now offering in-house monkeypox polymerase chain reaction (PCR) diagnostic testing for patients who are eligible.

By Jill Clendening
Gloved hands hold a blood sample tube labeled “Monkeypox,” with the positive box checked.
August 16, 2022

Q&A: Reassurance for parents on mpox risk, spread and symptoms

A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children.

By Jessica Pasley
Several vaccine vials labeled “Vaccine For Health Protection” arranged with a syringe on a white background.
September 22, 2020

Rational vaccine design

Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development.

By Leigh MacMillan
October 20, 2016

Preparing for a return of pox

To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.

By Bill Snyder